Citius Pharmaceuticals's total assets for Q2 2026 were $132.54M, a decrease of -5.59% from the previous quarter. CTXR total liabilities were $63.46M for the fiscal quarter, a 35.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.